![Brett Haumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brett Haumann
Directeur Général chez
Altesa Biosciences, Inc.
Profil
Dr. Brett K.
Haumann is an Operating Partner at SV Health Investors LLP, a Chief Executive Officer & Director at Altesa BioSciences, Inc., a Chief Executive Officer & Director at RIGImmune, Inc. and a Chief Medical Officer at ReViral Ltd. He is on the Board of Directors at Aravax Pty Ltd., Altesa BioSciences, Inc. and RIGImmune, Inc. Dr. Haumann was previously employed as an Independent Director by Aimmune Therapeutics, Inc., a Chief Medical Officer & Senior Vice President by Theravance Biopharma, Inc., a Vice President-Clinical Development & Operations by Theravance, Inc., a Director & Chief Medical Officer by Circassia Ltd., and a Vice President-Clinical Development by GlaxoSmithKline LLC.
He also served on the board at Reacta Biotech Ltd. He received his undergraduate degree from the University of the Witwatersrand and an MBA from The Open University.
Postes actifs de Brett Haumann
| Sociétés | Poste | Début |
|---|---|---|
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Directeur/Membre du Conseil | 06/05/2022 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 01/08/2023 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Directeur Général | 21/07/2026 |
Anciens postes connus de Brett Haumann
| Sociétés | Poste | Fin |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 05/04/2021 |
Reacta Biotech Ltd.
 Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Directeur/Membre du Conseil | 01/11/2016 |
| INNOVIVA, INC. | Corporate Officer/Principal | 01/06/2014 |
NIOX Healthcare Ltd.
 NIOX Healthcare Ltd. Pharmaceuticals: OtherHealth Technology Develops medicines for allergic and auto-immune diseases | Directeur Technique/Scientifique/R&D | 01/06/2013 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/08/2012 |
Formation de Brett Haumann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
NIOX Healthcare Ltd.
NIOX Healthcare Ltd. Pharmaceuticals: OtherHealth Technology Develops medicines for allergic and auto-immune diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Commercial Services |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Aravax Pty Ltd.
Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Health Technology |
RIGImmune, Inc.
 RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Commercial Services |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
